472.61歐元4(0.85%)
2023/02/03更新
績效 / 1月1.03%
3月5.65%
1年0.59%
晨星評等-
- 1.現金0.00%
- 2.股票37.23%
- 3.債券0.00%
- 4.其他62.77%
- 1.美國62.77%
- 2.歐洲不包含歐元區22.17%
- 3.日本5.11%
- 4.英國3.84%
- 5.歐元區3.55%
- 1.健康護理96.45%
- 2.工業1.83%
- 3.基本物料1.32%
- 4.防守性消費0.40%
- 1.UnitedHealth Group Inc9.07%
- 2.Novo Nordisk A/S Class B7.71%
- 3.Roche Holding AG6.59%
- 4.Elevance Health Inc5.46%
- 5.Amgen Inc5.33%
- 6.Vertex Pharmaceuticals Inc4.54%
- 7.Regeneron Pharmaceuticals Inc3.97%
- 8.GSK PLC3.84%
- 9.Gilead Sciences Inc3.17%
- 10.Intuitive Surgical Inc3.06%
- 1.現金0.00%
- 2.股票37.23%
- 3.債券0.00%
- 4.其他62.77%
- 1.健康護理96.45%
- 2.工業1.83%
- 3.基本物料1.32%
- 4.防守性消費0.40%
- 1.美國62.77%
- 2.歐洲不包含歐元區22.17%
- 3.日本5.11%
- 4.英國3.84%
- 5.歐元區3.55%
- 1.UnitedHealth Group Inc9.07%
- 2.Novo Nordisk A/S Class B7.71%
- 3.Roche Holding AG6.59%
- 4.Elevance Health Inc5.46%
- 5.Amgen Inc5.33%
- 6.Vertex Pharmaceuticals Inc4.54%
- 7.Regeneron Pharmaceuticals Inc3.97%
- 8.GSK PLC3.84%
- 9.Gilead Sciences Inc3.17%
- 10.Intuitive Surgical Inc3.06%